Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer GlobeNewswire - Mon Dec 16, 7:00AM CST

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals Grants Stock Options to New Employees Under 2021 Inducement Plan Quiver Quantitative, Inc. - Wed Dec 11, 5:54AM CST

Crinetics Pharmaceuticals granted stock options to 16 new employees under its 2021 Inducement Plan, totaling 146,400 shares.Quiver AI SummaryCrinetics Pharmaceuticals, Inc. announced the grant of non-qualified...

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Dec 10, 7:44PM CST

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals Announces FDA Acceptance of NDA for Paltusotine to Treat Acromegaly Quiver Quantitative, Inc. - Mon Dec 9, 5:22PM CST

Crinetics Pharmaceuticals' paltusotine NDA accepted by FDA, offering a potential new oral treatment for acromegaly.Quiver AI SummaryCrinetics Pharmaceuticals, Inc. announced that the FDA has accepted its...

CRNX : 53.60 (+1.63%)
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly GlobeNewswire - Mon Dec 9, 7:00AM CST

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences GlobeNewswire - Fri Nov 15, 8:00AM CST

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals to Showcase Novel Nonpeptide Drug Conjugate Platform and Phase 2 Data for Paltusotine at NANETS 2024 Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Crinetics Pharmaceuticals will present preclinical data on CRN09682 and Paltusotine at NANETS 2024.Quiver AI SummaryCrinetics Pharmaceuticals, Inc. announced the debut of its innovative nonpeptide drug...

CRNX : 53.60 (+1.63%)
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting GlobeNewswire - Thu Nov 14, 3:05PM CST

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting GlobeNewswire - Tue Nov 12, 3:07PM CST

CRNX : 53.60 (+1.63%)
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Nov 12, 3:05PM CST

CRNX : 53.60 (+1.63%)

Barchart Exclusives

Love Dividends? 2 Passive Income Stocks to Scoop Up Now. Barchart - 18 minutes ago
These consistent dividend-paying stocks could be a good addition to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot